Nephros, Inc. (NEPH)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$3.33
+3.10%
Mkt Cap $42.61M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $4.45M | $4.73M | +6.25% | $0.01 | $0.01 | +0.00% | — | — |
| Q4 2025 Nov 6, 2025 | $4.45M | $4.76M | +7.03% | $0.01 | $0.03 | +200.00% | — | — |
| Q3 2025 Aug 7, 2025 | $3.60M | $4.42M | +22.72% | -$0.03 | $0.02 | +180.00% | — | — |
| Q2 2025 May 15, 2025 | $3.62M | $4.88M | +34.69% | $0.01 | $0.05 | +400.00% | — | — |
| Q1 2025 Mar 24, 2025 | $3.67M | $3.87M | +5.41% | -$0.01 | $0.03 | +400.00% | — | — |
| Q4 2024 Nov 7, 2024 | $3.57M | $3.52M | -1.46% | $0.01 | $0.02 | +199.85% | — | — |
| Q3 2024 Aug 8, 2024 | $3.86M | $3.25M | -15.75% | -$0.01 | -$0.03 | -100.00% | — | — |
| Q2 2024 May 9, 2024 | $3.73M | $3.52M | -5.58% | -$0.01 | -$0.02 | -50.04% | — | — |
| Q1 2024 Mar 7, 2024 | $3.81M | $3.25M | -14.59% | -$0.03 | -$0.06 | -140.00% | — | — |
| Q4 2023 Nov 8, 2023 | $3.81M | $3.74M | -1.78% | -$0.06 | -$0.02 | +66.67% | — | — |
| Q3 2023 Aug 9, 2023 | $3.11M | $3.54M | +13.99% | -$0.05 | -$0.04 | +20.00% | — | — |
| Q2 2023 May 10, 2023 | $3.68M | $3.70M | +0.46% | -$0.02 | -$0.03 | -50.00% | — | — |
| Q1 2023 Feb 22, 2023 | $2.80M | $2.56M | -8.64% | -$0.06 | -$0.10 | -66.67% | — | — |
| Q4 2022 Nov 2, 2022 | $2.61M | $2.41M | -7.54% | -$0.12 | -$0.12 | +0.00% | — | — |
| Q3 2022 Aug 10, 2022 | $2.65M | $2.88M | +8.79% | -$0.14 | -$0.12 | +14.29% | — | — |
| Q2 2022 May 4, 2022 | $3.10M | $2.19M | -29.38% | -$0.13 | -$0.20 | -53.85% | — | — |
| Q1 2022 Feb 23, 2022 | $2.85M | $2.77M | -2.93% | -$0.10 | -$0.11 | -10.00% | — | — |
| Q4 2021 Nov 4, 2021 | $2.93M | $2.64M | -10.00% | -$0.12 | -$0.12 | +0.00% | — | — |
| Q3 2021 Aug 5, 2021 | $2.38M | $2.27M | -4.79% | -$0.12 | -$0.12 | +0.00% | — | — |
| Q2 2021 May 6, 2021 | $3.69M | $2.74M | -25.93% | -$0.14 | -$0.06 | +57.14% | — | — |